logo

United Therapeutics Corp (UTHR) Stock: A Comprehensive 52-Week Review

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. United Therapeutics Corp’s current trading price is -2.45% away from its 52-week high, while its distance from the 52-week low is 24.80%. The stock’s price range over this period has fluctuated between $204.44 and $261.54. The company, operating within the financial sector, had a trading volume of approximately 1.38 million for the day, which was noticeably higher than the average daily share volume of 0.48 million over the last 3 months.

In terms of market performance, United Therapeutics Corp had a fairly even. The highest value for the stock in the past year was $261.54 on 08/02/23, and the lowest value was recorded at $204.44 on 05/30/23.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

United Therapeutics Corp (UTHR) has experienced a quarterly rise of 18.79% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 11.32B and boasts a workforce of 1168 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 229.40, with a change in price of +15.16. Similarly, United Therapeutics Corp recorded 449,705 in trading volume during the last 100 days, posting a change of +6.32%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for UTHR stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.05.

UTHR Stock Stochastic Average

Today’s raw stochastic average for United Therapeutics Corp over the last 50 days is 92.40%.This indicates a increase from the raw stochastic average of the past 20 days, which was 88.39%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 72.32% and 68.38%, respectively.

UTHR Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. This year’s metric has recorded a Price increase of 16.03%. However, over the past six months, we’ve seen a weaker performance of 15.64%. The price of UTHR fallen by 11.62% over the last 30 days. And in the last five days, it has surged by 7.65%.

Most Popular